Staphylococcus Aureus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
Conditions: Catheter Bacteremia; Staphylococcus Aureus Infection Interventions: Drug: Dalbavancin; Other: Standard of care Sponsors: Centre Hospitalier Annecy Genevois; Centre Hospitalier de Perigueux; ADVANZ PHARMA; French National Network of Clinical Research in Infectious Diseases (RENARCI); Centre National de Reférence des Staphylocoques; Nantes University Hospital; APHP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Conditions: Staphylococcus Aureus Bacteremia; Staphylococcus Aureus Septicemia; Staphylococcal Sepsis; Staphylococcus Aureus Endocarditis Interventions: Drug: Ertapenem; Drug: Placebo Sponsor: Todd C. Lee MD MPH FIDSA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2021 Category: Research Source Type: clinical trials